chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she was not good with needles, so it was certainly good that it went quicker and less painful than she expected; This is a spontaneous report from a contactable consumer reporting for herself. An 18-year-old female patient received bnt162b2 (BNT162B2, lot number: EL1283, expiration date: not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The vaccine was administered at a school or student health clinic. The patient was not pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She was not diagnosed with COVID-19 prior to vaccination. Medical history and concomitant medication were not reported. The patient was just nervous for a good amount of the time. When she got the vaccine she was overthinking and her left hand began to throb. She was not in pain but just a sinking feeling. She stated that she was not good with needles, so it was certainly good that it went quicker and less painful than she expected. She added that her nurse treated her so well and was so patient with her and she appreciated it so much. Since the vaccination, the patient has been tested for COVID-19: Nasal Swab with result of negative on an unspecified date. No treatment was received for the event. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Patient describes feeling cold from the inside out and could not get warmed, this lasted for 4 to 5 days. He said that he was not running a fever, had aching joints, and head ache, these symptoms also lasted 4 to 5 days. The last thing that he described was hallucination that only occurred for a couple of hours on the day after the vaccination.
ARM SWOLLEN AND HOT TO THE TOUCH ALSO NOW HAS LIMITED RANGE OF MOTION SINCE RECEIVING VACCINE NO LONGER ABLE TO LIFT ARM ABOVE SHOULDER LEVEL
Pt reported having trouble swallowing 12 minutes after injection, escorted to med ops 1, no evidence of allergic reaction, no rash, no trouble breathing. Vitals monitored as follows: LYING 5:59 - HR 85, Resp 12, BP 135/81, Sp02 100 Standing 6:06 - HR 64, Resp 12, BP 142/82, Sp02 100
Client received Covid 19 vaccine at approx. 1530 to Rt. dlt.   Per Client at approximately 1900 with a dry tight throat then started shaking incontrollable like being cold.  Per client felt the same way when I had a reaction to prednisone.  Then after an hour extreme headache and increase blood pressure, chest pain, shortness of breath, body aches and fatigue.  Client voiced going to CMH ER around 1900.   Client voiced IV fluids given and no dx of allergic reaction with Covid vaccine was given from Dr. in ER.  Client refusal for 2nd dose- covid vaccine due to reaction from 1st vaccine.   Client does believe her MS that was in remission has flared back up since being vaccinated with Covid.
Initially ache in (L) arm escalating on pain scale to 10 by evening. Pt states she was unable to lift arm all the way up.
Shoulder injury related to vaccine administration.   Within 2 hours of receiving the shot, I experienced intense and nauseating shoulder pain as well as decreased strength and range of motion. I could not lift my arm. The pain radiating down to my wrist and up to my neck. I could not operate a motor vehicle. 10 days later, today, I am still experiencing pain with any should movement, particularly any heavy lifting. The pain is severe enough it is interfering with my sleep.
her daughter got the COVID shot and she's having heart issues; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization: series completed, Manufacturer: Unknown), for COVID-19 immunization. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "her daughter got the COVID shot and she's having heart issues".  Additional information: The caller was asking if there were any side effects in particular to heart Arrhythmias in relation to cardiomyopathy since her daughter got the COVID shot and she's having heart issues that she never had in her life.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2:00pm- Approximately 10 mins after covid vaccine, pt states throat tightening, itchy skin. Vomited milky emesis x 1, Denies sob/cp/dizziness No rash noted. A+o, speaking in full, clear sentences.   Placed on the gurney,  Contacted Covid MD, Dr.  Who did not want meds given- Wanted 911 called and to go to the ED. 911 called.  1402- 118/96 hr 123 SAT 96% 1408- 150/88 hr 122 SAT 97% 1413- 136/82 hr 112 SAT 97%   1415- EMTs arrived. Spoke with pt. Pt ref to go to the ED, stating feeling better.  1419- pt left after EMT assessment.
Loss of efficacy. Contracted asymptomatic Covid-19 post vaccination/Positive covid test result; Loss of efficacy. Contracted asymptomatic Covid-19 post vaccination/Positive covid test result; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  An 8 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date Dec2021 (Batch/Lot number: unknown) as dose 2 (tris), single and intramuscular, administered in arm left, administration date Nov2021 (Batch/Lot number: unknown) as dose 1 (tris), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. No known allergies. There is no COVID prior vaccination. There is no other vaccine in four weeks, and no Other medications in two weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "recovering" and all described as "Loss of efficacy. Contracted asymptomatic Covid-19 post vaccination/Positive covid test result". The patient underwent the following laboratory tests and procedures: PCR: (Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Blood clot on the cerebellum that caused a stroke; Blood  clot on the cerebellum that caused a stroke; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167), first dose via an unspecified route of administration, administered in Arm Left on 30Apr2021 11:30 (at 29 years old,(not pregnant), single dose for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medication included an unspecified vitamin.  The patient previously took ibuprofen and experienced Ibuprofen drug allergy. On 02May2021 08:30, patient experienced a Blood clot on the cerebellum that caused a stroke. The outcome of the events was recovering. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event resulted in visit to Emergency room/department or urgent care. Treatment received for the adverse event was Blood clot meds. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 (02May2021), negative for swab test. Events caused 3 days of hospitalization.  Information on Lot/Batch number was available. Additional information has been requested.
Paxlovid treats the covid-19; Paxlovid treats the covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown). The patient had no relevant medical history, no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Paxlovid treats the covid-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 20 month old female, with no medical history or known allergies, who on 5/21/01 was vaccinated with a dose of MMRII. There was no concomitant medication. On 5/31/01, 10 days later, the pt developed erythema multiforme minor, a temperature of 100F and rash which lasted several days. The physician reported that this was not a case of Stevens-Johnson syndrome. Medical attention was sought. The child was treated with Benadryl. Subsequently, the pt recovered "with no problem". Additional information has been requested.
very confused; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (very confused) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Dementia.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (very confused). At the time of the report, CONFUSIONAL STATE (very confused) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. Concomitant medications and treatment information were not provided.
TRIGGERED DORMANT CROHN'S DISEASE; This spontaneous report received from a patient via a company representative via social media (Janssen) concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: Crohns disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced vaccine triggered dormant Crohn's disease.  It was reported by patient that, "That vaccine triggered my dormant Crohn's disease Janssen ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of triggered dormant Crohn's disease was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220721787-covid-19 vaccine ad26.cov2.s - Triggered dormant Crohn's disease. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY. Therefore, this event(s) is considered not related.
child recvd vax & mom devel blisters, vesicles, fever, chills, cough & h/a;child had no sxs; mom was tested for varicella antibodies & was neg;
3 patients had a really bad rash that went from the injection site to their neck and a couple of the patients had the rash go to their face on an unknown date after being administered the PNEUMOVAX 23; 3 patients had a really bad rash that went from the injection site to their neck and a couple of the patients had the rash go to their face on an unknown date after being administered the PNEUMOVAX 23; 3 patients had a really bad rash that went from the injection site to their neck and a couple of the patients had the rash go to their face on an unknown date after being administered the PNEUMOVAX 23; This spontaneous report was received from a pharmacist concerning to a 3 unspecified patients of unknown age (reported as all over of 65 years old). Information regarding the patients' medical history, concurrent condition and concomitant medications was not reported.   In March 2019 (reporter as the last week to 10 days) the patients were vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX 23) for prophylaxis (strength, dose, route of administration, lot # and expiration date were not reported). The pharmacist reported that the all of doses that were administered were from the same lot number.     On an unknown date, the 3 patients had a really bad rash that went from the injection site to their neck and a couple of the patients had the rash go to their face after being administered the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX 23) (injection site rash and rash).  The patients called to the pharmacy to sought medical attention.   The outcome of the adverse events was unknown.  The causality between pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX 23) and the adverse events was not reported.
As per nurse on site, patient stated feeling dizzy approximately 2 minutes after vaccine administration.   Patient had syncopal episode with decreased O2 sats .  Due to slow recovery from symptoms 911 was called and patient was transported by EMS to nearest emergency room.
Egg sized swelling accoompanied by soreness and stiffness of upper arm. Skin over the site became black and blue. This persisted for 5 weeks although the swelling and soreness decreased over time
initially had blister the day of the immunization at the injection site. 9 days later, patient noticed the blister had formed into a hard nodule, her arm was red and swollen and warm to the touch on the whole upper part of her left arm, and it was itchy.  she contacted her primary care physician, who directed her to the pharmacy.  this was still going on 72 hours after noticing initial symptoms
Patient stated arm sore one to two days after injection. Then 8 days after initial injection arm sore and slightly edematous apprx golf ball size. Patient took Ibuprofen and swelling subsided. Continues to complain of soreness at the time of todays visit "5-7-18".
This spontaneous report was received from a female patient of unknown age regarding herself. The patient's concurrent condition, medical history, concomitant medication and drug allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot#, expiry date, dose, units and route were not specified). The illness of patient/sibling at the time of vaccination was not reported. On an unknown date the patient reported that she had pain in the front and back of her body, and at the injection site (specific area unspecified), she also explained that the pain had become very sensitive at the injection site. The outcome of events was unknown at the reporting time. No product quality complaint (PQC) was filed. Causality assessment was not provided. Additional information is not expected as no reporter details were provided.
FEVER; FLU LIKE SYMPTOMS; CHILLS; DIARRHEA; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1806609, expiry date: unknown) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination at left deltoid. Concomitant medications included paracetamol for arthritis. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced flu like symptoms. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced diarrhea. On MAR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms, chills, and diarrhea on MAR-2021, and was recovering from fever, and headache. This report was non-serious.
pt presents to hospital with c/o SOB, body aches, facial pain, N/V/D, cough x past 4-5 days; found to be positive for COVID; O2 supplementation; remdesivir; steroids; pt arrested requiring intubation; transferred to ICU; pt hypotensive and bradycardic, progressed to PEA arrest; daughter then decided upon DNR for pt; bilateral COVID pneumonia; pt worsened and expired in the hospital
Hives presenting all over my body after a recent sinus infection three weeks ago.  I get sinus infections yearly and never have I had hives after being sick, except for the year I get the covid vaccine.
Patient hospitalized for Lumbar 2-3, 3-4 and 4-5 transforaminal lumbar interbody fusion within 6 weeks of receiving covid vaccination.
On 8/26/2022 I tested positive for COVID (home test) and went to my primary doctor. This was a year and seven months after my first dose. I did receive a second dose and two boosters with the last booster 03/31/2022. She prescribes Paxlovid. I took that but suffered rebound about a week after the Paxlovid treatment. I have recovered.
Started with rash, intense itching, burning and tingling of the skin with the exception of hands, feet and face. Then started muscle spasms, cramping and involuntary muscle contractions. Jaw and hands would lock up. Severe pain in muscles and joints. Walking was difficult because it felt like I did not have control of my legs and feet. Developed hoarseness almost immediately. Pulmonary Doctor confirmed inflamation in the lungs. Had an episode of AFIB and Cardiologist could find nothing wrong with my heart. Skin burning so severely I struggled t sleep any length of time. Dermatologist tried topical steroid cream and allergy medication. To no avail. Family doctor, Dr perscribed mulitiple regiments of Prednison Pednisone made the symptoms mitigate temporarily. However, I still suffer from chronic symptoms although they are not as debilitating.  This form would not let me finish the information about the fist Covid 19 vaccine. It was given on 07?20/2021 and was the first dose in the series.
Doctor called Hlth. Dept. and said client had chickenpox all over body.  Client was seen yester-day in Dr.'s ofc.  Client was running a fever.
Loss of appetite; Body aches all over; Loss of taste; Headache which doesn't go away; Fever; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite), HEADACHE (Headache which doesn't go away), PYREXIA (Fever) and MYALGIA (Body aches all over) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B214 (or 9) and C41C21A) for COVID-19 vaccination.     No historical condition was reported.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced AGEUSIA (Loss of taste), HEADACHE (Headache which doesn't go away) and PYREXIA (Fever). On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite) and MYALGIA (Body aches all over). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at a dose of 500 mg and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 200 mg. At the time of the report, AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite), HEADACHE (Headache which doesn't go away), PYREXIA (Fever) and MYALGIA (Body aches all over) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jun-2021, Body temperature increased: 99.3 (High) High and 103.5 (High) High.         No relevant concomitant medication was reported
Headache, Myalgia, Fever, Nausea Vomiting & Fatigue
First noticed 9 am 3/24/21 the pupils of both eyes are constricted, and have remained so  to 5 pm. Approaching 24 hrs since dose 1 vaccination, pupils have not changed. Injection site somewhat sore, fuzzy headed feeling seems to be diminishing. No other symptoms at this time.
After the vaccine few hours later my left arm went numb. I  went to the ER physician told me that was not a reaction to the vaccine and prescribed me a prescription for Prednisone, Allergy medication. I missed a total of I  hour 1/2 from work.
This spontaneous report as received from internet referred to a female patient of unknown age. On an unknown date the patient was vaccinated with her first booster shot of GARDASIL (Lot#, dose/frequency, route and duration were unspecified) on May 2. A family friend of the patient said that, "Her legs are paralyzed, her arms are affected. She is very weak in her arms," "She has to use a walker. Even with that, she can't get to the bathroom. She can't stand up at all." Patient had been determined by her doctor to have Guillain-Barre syndrome, an acute, autoimmune condition that could lead to paralysis. At the time of reporting, outcome and relationship were unknown. Upon internal review, Guillain-Barre syndrome was considered as other medical significant event. This is one of several reports that received from the same source. Additional information has been requested.
At 5 a.m. I woke up with abdominal cramps and felt sweaty.  I had an episode of liquid diarrhea and had smaller loose stools for 1-2 hours after that.  I did not need any medical care and did not report this. It was brief and resolved by afternoon.  I have not had this before and attributed it to the second vaccine dose.  I otherwise felt fine after the vaccine.
Started with intermittent Chest pain which I didn?t do anything about and ignored at first and then it progressed to more constant chest pain  on Or around April 25th which I went to the ER twice and urgent care once in 2 days time between April 29 an April 30
Pt recv vax on 10/14/97; 20 min post vax pt exp bright lights in the central & peripheral field of vision
DECREASED LEVEL OF CONSCIOUSNESS AND HARD TO AROUSE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included dementia. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the patient got a temperature, experienced decreased level of consciousness and was hard to arouse.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the decreased level of consciousness and hard to arouse, fever was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0. 20210354631-COVID-19 VACCINE AD26.COV2.S-Decreased level of consciousness and Hard to arouse. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).